Grifols Accuses Gotham of Obstructing the Obtaining of Evidence to Prepare for Trial in New York
El fondo norteamericano aguarda a que la justicia resuelva definitivamente su solicitud de protección para no entregar toda la documentación reclamada por la farmacéutica
Tension between Grifols and Gotham City Research continues to rise at a key moment in the defamation case in New York. The plasma derivatives company has accused the US fund of obstructing the delivery of agreed-upon documentation to prepare for the trial to be held in 2027. Gotham, which in January 2024 released a report on Grifols' accounts that caused its stock to plummet, has refused to provide extensive information pending a definitive judicial ruling on whether it can avail itself of the same legal shield as journalists to protect its freedom of expression.
However, for the Spanish company, the investment firm is using this privilege as a "sword and shield", invoking it only to avoid material it considers most sensitive while voluntarily providing other information that supports its position.
Translated by urgent.news. Machine-written — may contain errors; check the original before relying on it.
